96573 ⎘
Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms Expansion of ring D by one atom, e.g. D homo steroids
2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#2COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#3STEROID COMPOUND, AND USE THEREOF AND PREPARATION METHOD THEREFOR
#4ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#5URSOLIC ACID DIETHANOLAMINE SALT
#6SODIUM SALT AND ETHANOLAMINE SALT OF 23-HYDROXYTORMENTIC ACID
#7BETULASTATIN COMPOUNDS
#8URSOLIC ACID MORPHOLINE SALT
#9COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#10METHOD FOR RECOVERING OF HIGH PURITY BETULIN FROM BIRCH BARK
#11NOVEL BETULIN DERIVATIVES, AND THEIR MANUFACTURING METHOD AND USE AS SURFACTANT
#12TARGETED COMPOSITIONS
#13CELASTROL SALTS, CRYSTALLINE FORMS, AND USES THEREOF
#14SAPONIN-BASED ADJUVANTS AND VACCINES
#15COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA
#162,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#17Ursolic acid morpholine and diethanolamine salts
#18CELASTROL PROTEOLYSIS TARGETING CHIMERAS
#19POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF
#20TRITERPENE SAPONIN ANALOGUES
#21ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#22COMPOUNDS FOR TREATING CNS DISORDERS
#23FLUORINATED AND ALKYLATED BILE ACIDS
#24PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#25TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS
#262,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#27COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA
#28ANALOGS OF CELASTROL
#29SYNTHETIC URSOLIC ACID DERIVATIVES AND METHODS OF USE THEREOF
#30URSOLIC ACID PREPARATIONS AND USES THEREOF
#31COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#32ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM
#33Saponin derivatives with improved therapeutic window
#34TRITERPENE SAPONIN VARIANTS, METHODS OF SYNTHESIS AND USE THEREOF
#35NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
#36C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
#37PURIFIED SAPONINS AND CHROMATOGRAPHIC PROCESS FOR PURIFICATION OF SAME
#38GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA
#39Saponin purification
#40COMPOUNDS FOR TREATING CNS DISORDERS
#41C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES
#42Triterpene saponin analogues
#43Betulastatin compounds
#44COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY
#45NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS
#46SYNTHETIC TRITERPENOIDS WITH NITROGEN-BASED SUBSTITUENTS AT C-17 AND METHODS OF USE THEREOF
#47COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#48OLEAN-PHENYLACRYLAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF
#49TRITERPENOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING A NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1-MEDIATED DISEASE
#50COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#51TRITERPENE GLUCURONIDES AND THEIR USE AS FLAVOR MODIFIERS
#52COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE
#53SAPONIN PURIFICATION
#54METHODS AND COMPOSITIONS FOR IRREVERSIBLE ENZVME INHIBITION
#55NOVEL TRITERPENONE DERIVATIVES AS HIV INHIBITORS
#56Glycyrrhetinic acid derivatives for use in treating hyperkalemia
#57STEROID COMPOUND, AND USE THEREOF AND PREPARATION METHOD THEREFOR
#582,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#59COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY
#60Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#61TERPINOID DERIVATIVES AND USES THEREOF
#62Fluorinated and alkylated bile acids
#632,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#64COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY
#65C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
#66Triterpene amine derivatives
#67NOVEL FORM OF BARDOXOLONE METHYL
#68Betulastatin compounds
#69Glycyrrhetinic acid derivatives for treating hyperkalemia
#70C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
#71COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE
#72Analogs of celastrol
#73SAPONIN-BASED VACCINE ADJUVANTS
#74Saponin adjuvant and evaluation method thereof
#75TRITERPENE SAPONIN ANALOGUES
#76Triterpenoids with HIV maturation inhibitory activity
#77Saponin purification
#78Triterpene saponin analogues
#79Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
#80Pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereof
#81URSOLIC ACID MORPHOLINE AND DIETHANOLAMINE SALTS
#82Natural and synthetic compounds for treating cancer and other diseases
#83Synthesis of ursolic acid nanoparticles
#84Synthesis of ursolic acid nanoparticles
#85Synthesis of ursolic acid nanoparticles
#86C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
#87C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
#882,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#89C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
#90BETA-ADRENERGIC BLOCKING COMPOUND
#91Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof
#92Method for modifying T cell population
#93Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
#94Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#95Method for Producing Soyasaponins
#96Targeted nucleic acid conjugate compositions
#97C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
#98Triterpenoids with HIV maturation inhibitory activity
#99TRITERPENOID INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#100Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#101C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
#102AMINE DERIVATIVES OF LUPANES WITH HIV MATURATION INHIBITORY ACTIVITY
#103Triterpene saponin variants, methods of synthesis and use thereof
#104Analogs of celastrol
#105Methods and compositions for treatment of COPD diseases
#106C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors
#107COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY
#108Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound
#109C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
#110C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
#111BETUIN DERIVATIVES FOR PREVENTING OR TREATING HIV INFECTIONS
#112C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
#113BETUIN DERIVATIVES FOR PREVENTING OR TREATING HIV INFECTIONS
#1142,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#115CRYSTALLINE FORMS OF MODIFIED TRITERPENOID HYDROCHLORIDE SALTS WITH HIV MATURATION INHIBITOR ACTIVITY
#116Methods of producing an HIV maturation inhibitor
#117Fluorinated and alkylated bile acids
#118PHARMACEUTICAL COMPOSITIONS
#119Terpenoid derivatives
#1202,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#121Antioxidant Inflamation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#122POLYMORPHS OF CDDO ETHYL ESTER AND USES THEREOF
#123DERIVATIVES OF BETULIN
#124Triterpenoids with HIV maturation inhibitory activity
#125Oxolupene derivatives
#126Extended betulinic acid analogs
#127C17-aryl substituted betulinic acid analogs
#128Modulators of ROR-gamma Receptors, Composition and Use Thereof
#129Natural and synthetic compounds for treating cancer and other diseases
#130Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof
#131Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#132C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
#133Compounds and compositions for treating HIV with derivatives of Betulin
#134Betulinic acid derivatives with HIV maturation inhibitory activity
#135TGR5 agonist complexes for treating diabetes and cancer
#136Betulinic proline imidazole derivatives as HIV inhibitors
#137NOVEL BETULINIC PROLINE IMIDAZOLE DERIVATIVES AS HIV INHIBITORS
#138Fused triterpene compounds and uses thereof
#139Extended Triterpene Derivatives
#140Process for extraction of saponins from agricultural products
#141Natural and synthetic compounds for treating cancer and other diseases
#142C-3 NOVEL TRITERPENONE WITH C-28 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS
#143Pentacyclic triterpenoid compound with modified structure and preparation method and use thereof
#144Glycyrrhetinic acid derivative and use thereof
#145Terpenoid derivatives
#146General catalyst for C-H functionalization
#147Method of using supercritical fluid technology to separate and purify functional components of Antrodia camphorata
#148Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
#149Pentacyclic triterpene compounds and uses thereof
#150CYRRHETINIC ALKYL ESTERS AND PROTECTED DERIVATIVES THEREOF
#151Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof
#152Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#153N-acetyl amino acid ESTER derivatives of betulin and preparation method thereof
#154Esters of glycyrrhetinic acid, preparation and cosmetic applications thereof
#155Betulinic acid proline derivatives as HIV inhibitors
#156Pharmaceutical compositions
#157Triterpenoids with HIV maturation inhibitory activity
#158Triterpene derivative and its anti-influenza use
#1592,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#160Ursolic acid derivative and method for preparing same
#161C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
#162A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
#163Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
#164Triterpenoids and compositions containing the same
#165Lupane triterpenoid derivatives and pharmaceutical use thereof
#166URSOLIC ACID SALTS FOR TREATING DIABETES AND OBESITY
#167Amooranin compounds and analogs thereof and related methods of use
#168Propenoate derivatives of betulin
#1692-substituted oleanolic acid derivative, method preparing for same, and application thereof
#170COMPOSITIONS HAVING C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY
#1712,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#172Natural and synthetic compounds for treating cancer and other diseases
#173Polymorphs of CDDO ethyl ester and uses thereof
#174Amorphous asiatic tromethamine salt and preparation method thereof
#175Purification methods for betulonic acid and Boc-lysinated betulonic acid, and organic synthesis of betulonic acid amides with piperazine derivatives
#176C-3 alkyl and alkenyl modified betulinic acid derivatives
#177C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY
#178Natural and synthetic compounds for treating cancer and other diseases
#179Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
#180C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
#181C13-hydroxy derivatives of oleanolic acid and methods of use thereof
#182Betulonic and betulinic acid derivatives
#183Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#184Compounds for treating cancer and other diseases
#185Synthesis and use of anti-tumor drug LQC-Y
#1862,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#187Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#188Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
#189Triterpenoids and compositions containing the same
#190C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
#191C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
#192PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF
#193Derivatives of betulin
#194Process for production of triterpene alcohol
#195Novel Salts Of Boswellic Acids And Selectively Enriched Boswellic Acids And Processes For The Same
#196Derivative of 18β-glycyrrhetinic acid apt to suppress cancer cells
#197Derivatives of 3-O-(3',3'-dimethylsuccinyl)-betulinic acid
#198Neuro-protective compounds and their use
#19918β-Glycyrrhetinic acid derivatives and synthetic method thereof
#200Betulinic acid derivatives with antiviral activity
#201C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
#202C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitors
#203Forms of CDDO methyl ester
#20423-HYDROXY-BETULINIC ACID DERIVATIVES, PREPARATION METHODS AND USES THEREOF
#205COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
#206C4 monomethyl triterpenoid derivatives and methods of use thereof
#207TRITERPENE DERIVATIVE AND AGENT FOR PREVENTING OR TREATING CHRONIC HEPATITIS C
#208Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
#209Antioxidant inflammation modulators: novel derivatives of oleanolic acid
#210Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
#211Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
#212GLYCYRRHETINIC ACID ESTER DERIVATIVE SYNTHESIS METHOD AND DEOXOGLYCYRRHETINIC ACID ESTER COMPOUND
#213Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
#214C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
#215Adjuvant
#216COMPOUND USED TO PREVENT DISEASES CAUSED BY AQUAPORIN DEFICIENCY
#217Triterpenoid derivatives useful as antiproliferative agents
#218Enhanced neoglycosides through neoglycosylation and methods of use thereof
#2193,28-DISUBSTITUTED BETULINIC ACID DERIVATIVES AS ANTI-HIV AGENTS
#220Forms of CDDO methyl ester
#221Certain chemical entities, compositions, and methods
#222Extended triterpene derivatives
#223Analogs of 3-O-acetyl-11-keto-beta-boswellic acid
#224Delayed release, oral dosage compositions that contain amorphous CDDO-Me
#225N-hydroxy C29-amide derivatives of oleandrane
#226Preparation of Pharmaceutical Salts of 3-0-(3',3'-Dimethylsuccinyl) Betulinic Acid
#227Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
#228Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#229Fast isolation method for the natural scaffold ursolic acid from
#230BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS
#231Pharmaceutically acceptable salts of betulinic acid derivatives
#232Triterpenoid 2-deoxy glycosides, method of preparation thereof and use thereof as medicaments
#233Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma
#234BETULINIC ACID DERIVATIVES AS ANTI-HIV AGENTS
#235C-21-keto lupane derivatives preparation and use thereof
#236Lupane derivatives useful for treating HIV
#23718β-glycyrrhetinic acid derivatives and synthetic method thereof
#238Lupeol-type triterpene derivatives as antivirals
#239Therapeutic formulations based on asiatic acid and selected salts thereof
#240Compositions and methods for inhibiting growth and metastasis of melanoma
#241Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
#242COMPOUNDS AND THERAPEUTIC USES THEREOF
#243COMPOSITIONS AND METHODS FOR POTENTIATING ANTIBIOTIC ACTIVITY
#244Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
#245Glycyrrhetinic acid derivatives
#246Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
#247Antioxidant inflammation modulators: novel derivatives of oleanolic acid
#248Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#249Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
#250METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS
#251Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation
#252Method of preparation and isolation of betulin diacetate from birch bark from paper mills and its optical processing to betulin
#253USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID
#254D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands
#255STEROIDS HAVING A MIXED ANDROGENIC AND PROGESTAGENIC PROFILE
#256Process for preparing high purity corosolic acid and high purity ursolic acid
#257ANTIVIRAL COMPOUNDS AND USE THEREOF
#258BIRCH BARK PELLETIZATION AND METHODS FOR OBTAINING NATURAL PRODUCTS FROM BIRCH BARK PELLETS
#259Betulinic acid, derivatives and analogs thereof and uses therefor
#260Compositions and Uses of Amooranin Compounds
#261METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS
#262ANTIVIRAL COMPOUNDS
#263SYNTHESIS OF BETULONIC AND BETULINIC ALDEHYDES
#264SELECTIVE OXIDATION OF TRITERPENES EMPLOYING TEMPO
#265Derivatives of 18Beta-Glycyrrhetinic Acid
#266Betulonic and betulinic acid derivatives
#267Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris
#268Compositions and methods for inhibiting growth and metastasis of melanoma
#269COMBINATION THERAPY WITH SYNTHETIC TRITERPENOIDS AND GEMCITABINE
#270Forms of CDDO methyl ester
#27117alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
#272NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME
#273METHODS OF MANUFACTURING BIOACTIVE 3-ESTERS OF BETULINIC ALDEHYDE AND BETULINIC ACID
#274Steroidal compounds for inhibiting steroid sulphatase
#275Compounds, compositions and methods for controlling biofilms and bacterial infections
#276Crystal of triterpene derivative
#277TRITERPENE QUATERNARY SALTS AS BIOLOGICALLY ACTIVE SURFACTANTS
#278TRITERPENE QUATERNARY SALTS AS BIOLOGICALLY ACTIVE SURFACTANTS
#279TRITERPENE QUATERNARY SALTS AS BIOLOGICALLY ACTIVE SURFACTANTS
#280Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
#281SUBSTITUTED TARAXASTANES USEFUL FOR TREATING VIRAL INFECTIONS
#282Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
#283Anti-tumor compounds with angeloyl groups
#284Steroids having a mixed androgenic and progestagenic profile
#285Chemical entities with multiple modes of anti-inflammatory action
#286PROCESS FOR THE EXTRACTION OF BETULINIC ACID
#287Process for the isolation of oleane compounds isolated from the bark of arjun tree terminalia arjuna (Roxb.)
#288Steroidal compounds for inhibiting steroid sulphatase
#289Early insulin secretion stimulator
#290Triterpene quaternary salts as biologically active surfactants
#291Method of preparing and use of prodrugs of betulinic acid derivatives
#292Pomolic acid, its isomers, derivatives and their uses, pharmaceutical composition, method to prepare the pharmaceutical composition and method for treating multidrug resistant tumours
#293Compositions and uses of Amooranin compounds
#294Triterpenoid derivatives
#295Analogs of 3-O-acetyl-11-keto-β-boswellic acid
#296Methods of treating fungal infections using lupeol
#297Methods and compositions for inhibiting biofilms
#298Anti-retroviral moronic acid derivatives
#299Pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
#300Use of hederagenin 3-O-α-L-rhamnopyranosyl(1-2)-[β-D-glucopyranosyl(1-4)]-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors